性別適合手術の米国市場2020-2027:性別分析(男性-女性、女性-男性)

【英語タイトル】U.S. Sex Reassignment Surgery Market Size, Share & Trends Analysis Report By Gender Transition (Male To Female, Female To Male), And Segment Forecasts, 2020 - 2027

Grand View Researchが出版した調査資料(GV21JA073)・商品コード:GV21JA073
・発行会社(調査会社):Grand View Research
・発行日:2020年12月28日
・ページ数:90
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:米国
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥642,600見積依頼/購入/質問フォーム
Multi UserUSD6,950 ⇒換算¥750,600見積依頼/購入/質問フォーム
Enterprise UserUSD8,950 ⇒換算¥966,600見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
グランドビューリサーチ社は、性別適合手術の米国市場規模が2027年までに781.8百万ドルに達すると予測しています。2020年から2027年までに年平均14.4%成長する見通しです。本市場調査資料では、性別適合手術の米国市場を広く調査・分析し、手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、性別分析、競争定性など、以下の構成でまとめております。
【レポートの概要】

U.S. Sex Reassignment Surgery Market Growth & Trends
The U.S. sex reassignment surgery market size is expected to reach USD 781.8 million by 2027, based on a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 14.4% from 2020 to 2027. There are around 198.5 million Americans aged 20 – 65, accounting for 60% of the population, out of which 0.6% identify themselves as transgender as per the 2016 report of the Williams Institute, UCLA. People of this age group are considered to be the target population for this market.

According to the Plastic Surgery Statistics by the American Society of Plastic Surgeons, Americans aged 40 of 54 opted for 49% of cosmetic surgeries in the U.S. including 7.9 million total cosmetic procedures, 568,000 surgical procedures, and 7.3 million minimally invasive surgeries. Furthermore, USD 16.7 billion were spent on cosmetic procedures in the U.S., out of which the age group of 20 – 65 accounted for more than 50% of surgeries in 2019. This is expected to drive the market during the forecast period.

The U.S. sex reassignment surgery providers are engaging in new facility launches to strengthen their market presence. For instance, in September 2020, seven hospital facilities within the Mount Sinai Health System have been recognized as national leaders in LGBTQ health care equality by the Human Rights Campaign Foundation’s 2020 Healthcare Equality Index (HEI).

U.S. Sex Reassignment Surgery Market Report Highlights

• By gender transition, the female to male segment held the largest revenue share in the market in 2019. Demand for U.S. sex reassignment surgery is increasing due to an increase in the number of people opting for sex-change surgeries and growing awareness and acceptance of the transgender community

• There are around 198.5 million Americans aged 20 – 65, accounting for 60% of the population out of which ~0.6% identify themselves as transgender as per the 2016 report of the Williams Institute, UCLA. People of this age group are considered to be the target population for this market

• The increasing number of sex reassignment surgeries is among the major factors driving the sex reassignment surgery market. Rise is seen among the patients choosing to change their sex from female to male and male to female, which has increased nearly four times ever since the last decade

【レポートの目次】

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 GVR’s Internal Database
1.3.3 Secondary sources
1.3.4 Primary research
1.4 Information or Data Analysis
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity flow analysis
1.6.2 Volume price analysis
1.7 List of Secondary Sources
1.8 List of Abbreviations
1.9 Objectives
1.9.1 Objective – 1
1.9.2 Objective – 2
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Competitive Insights
Chapter 3 Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.2 Market Dynamics
3.2.1 Market driver analysis
3.2.1.1 Increase in the number of people opting for sex change surgeries
3.2.1.2 Increasing incidence rate of gender dysphoRIA
3.2.2 Market restraint analysis
3.2.2.1 High cost of the procedures
3.2.2.2 Risks associated with surgical procedures
3.3 U.S. SRS Market: Business Environment Analysis Tools
3.3.1 PESTEL Analysis
3.3.1.1 Political landscape
3.3.1.2 Economic and social landscape
3.3.1.3 Technology landscape
3.3.2 Porter’s five forces analysis
3.3.2.1 Competitive Rivalry: High
3.3.2.2 Threat of New Entrants: Moderate
3.3.2.3 Bargaining Power of Suppliers: Moderate
3.3.2.4 Threat of Substitutes: Moderate
3.3.2.5 Bargaining Power of Buyers: Low
3.4 Qualitative Analysis: Impact of COVID-19 on Assisted Living Facilities
Chapter 4 U.S. Sex Reassignment Surgery (SRS) Market: Gender Transition Analysis
4.1 U.S. SRS Gender Transition Market Share Analysis, 2019 & 2027
4.2 U.S. SRS Gender Transition Market: Segment Dashboard:
4.3 Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the Gender Transition Segment
4.3.1 Male to Female
4.3.1.1 Male to female market, 2016 – 2027 (USD Million)
4.2.1 Female to Male
4.2.1.1 Female to male market, 2016 – 2027 (USD Million)
Chapter 5 U.S. Sex Reassignment Surgery (SRS) Market- Competitive Qualitative Analysis
5.1 Recent Developments & Impact Analysis, by Key Market Participants
5.2 Strategic Framework/Competition Categorization (Key Innovators, Market Leaders, Emerging Players
5.3 Heat Map Analysis/Market Position Analysis
5.4 Key Company Profiles: Sex Reassignment Surgery Companies
5.4.1 Mount Sinai
5.4.1.1 Company overview
5.4.1.2 Financial performance
5.4.1.3 Service benchmarking
5.4.1.4 Strategic initiatives
5.4.2 Transgender Surgery Institute of Southern California
5.4.2.1 Company overview
5.4.2.2 Service benchmarking
5.4.3 Cedars Sinai
5.4.3.1 Company overview
5.4.3.2 Financial performance
5.4.3.3 Service benchmarking
5.4.3.4 Strategic initiatives
5.4.4 Moein Surgical Arts
5.4.4.1 Company overview
5.4.4.2 Service benchmarking
5.4.5 Boston Medical Center
5.4.5.1 Company overview
5.4.5.2 Financial performance
5.4.5.3 Service benchmarking
5.4.6 Cleveland Clinic
5.4.6.1 Company overview
5.4.6.2 Financial performance
5.4.6.3 Service benchmarking
5.4.7 CNY Cosmetic & Reconstructive Surgery
5.4.7.1 Company overview
5.4.7.2 Financial performance
5.4.7.3 Service benchmarking
5.4.8 Plastic Surgery Group Rochester
5.4.8.1 Company overview
5.4.8.2 Service benchmarking

List of Tables

TABLE 1 List of secondary sources
TABLE 2 List of abbreviations
TABLE 3 SRS surgeries and associated Risks


List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain-based sizing & forecasting
FIG. 6 QFD modeling for market share assessment
FIG. 7 Market formulation & validation
FIG. 8 Market driver relevance analysis (Current & future impact)
FIG. 9 Market restraint relevance analysis (Current & future impact)
FIG. 10 U.S. Sex Reassignment Surgery (SRS) market, 2016 - 2027 (USD Million)
FIG. 11 Recent developments & impact analysis, by key market participants
FIG. 12 Strategy framework
FIG. 13 Company market position analysis

★調査レポート[性別適合手術の米国市場2020-2027:性別分析(男性-女性、女性-男性)] (コード:GV21JA073)販売に関する免責事項を必ずご確認ください。
★調査レポート[性別適合手術の米国市場2020-2027:性別分析(男性-女性、女性-男性)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆